Correvio Pharma Corp. Long-Term Debt, Maturity, Year Five
Correvio Pharma Corp. had Long-Term Debt, Maturity, Year Five of $0 as of 2018-12-31, per its 40-F filed 2019-03-13.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2019-03-13
- 2018-12-31: Long-Term Debt, Maturity, Year Five $0.00.
- 2017-12-31: Long-Term Debt, Maturity, Year Five $8.36M.
- 2016-12-31: Long-Term Debt, Maturity, Year Five $2.50M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2018-12-31 | $0.00 40-F · filed 2019-03-13 |
| 2017-12-31 | $8.36M 20-F · filed 2018-04-30 |
| 2016-12-31 | $2.50M 40-F · filed 2017-03-29 |